Snail, Inc. Reports Fourth Quarter & Full Year 2023 Financial Results

Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data. Read More

CureVac to Report Fourth Quarter and Full-Year 202…

("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), will report financial results, and provide business ... Read More

4Front Ventures Reports Fourth Quarter and Full Year 2023 Financial Results

In this press release, 4Front refers to certain non-GAAP financial measures, in addition to GAAP financial measures. 4Front's management uses these non-GAAP measures to understand and compare ... Read More

Snail, Inc. Reports Fourth Quarter & Full Year 2023 Financial Results

View original content:https://www.prnewswire.com/news-releases/snail-inc-reports-fourth-quarter--full-year-2023-financial-results-302104231.html ... Read More

iLearningEngines Reports Fourth Quarter and Full Year 2023 Results

Fourth quarter revenue grew 39% year-over-year to $116 million Posts record full year revenue of $421 million, up 36% year-over-year, and ARR growth accelerates to 43% year-over-year BETHESDA, Md. Read More

Snail, Inc. Reports Fourth Quarter & Full Year 2023 Financial Results

Survival Evolved units sold increased for the fourth quarter 2023 compared to the same period in 2022; approximately 0.7 million vs. 1.6 million, respectively. Units sold decreased for the year ... Read More

KIDPIK Reports Fourth Quarter and Full Year 2023 Financial Results

Kidpik will not be holding an earnings call to discuss fourth quarter 2023 or year-end 2023 results, as the Company moves forward with the Merger. About Kidpik Corp. Founded in 2016, KIDPIK ... Read More

Snail, Inc. Reports Fourth Quarter & Full Year 2023 Financial Results

today announced financial results for its fourth quarter and full year ended December 31, 2023. “This past year has been filled with exciting milestones for Snail. We launched ARK: Survival ... Read More

TerrAscend Reports Fourth Quarter and Full Year 2023 Financial Results

Fourth Quarter 2023 Financial ... Annual Report for the year ended December 31, 2023 filed with the Securities and Exchange Commission on March 14, 2024. The statements in this press release ... Read More

GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results

Fourth Quarter and Year End 2023 Financial Summary Cash Position: The Company had cash, cash equivalents and short-term investments of $13.97 million as of December 31, 2023 compared to $16.51 ... Read More